Bay Street News, December, 2018

   WT1 is a Well-Characterized Oncofetal Antigen, Expressed in Solid Tumors and Hematologic Malignancies CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) — […]

20-Year Power Purchase Agreement executed for 7.4 MW Project in Yaphank, NY Advances LIPA and PSEG Long Island efforts to […]

CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) — VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation […]

Pratik Shah., Ph.D., Appointed Chairman of the Board SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) — Synthorx, Inc. (NASDAQ: THOR), […]

Top-line data anticipated in the third quarter of 2019 SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: […]

By dropping its appeal, Axon concedes the validity of the ‘292 Patent and has no further pending Patent Office challenges […]

TAMPA, Fla., Dec. 20, 2018 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a […]

ELMSFORD, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary […]

– President and CEO Sean McCarthy, D. Phil., Appointed to Additional Role of Chairman –   – Hoyoung Huh, M.D., Ph.D. […]

LOS ANGELES, Dec. 20, 2018 (GLOBE NEWSWIRE) — Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, […]